Aug 20, 2014
LONDON, UK, 19th August 2014: A new report by visiongain predicts that the world market for allergic rhinitis drugs will reach $11.3bn in 2014.
Aug 19, 2014
LONDON, UK. 15th August 2014: A new forecast report released today by visiongain, an independent business intelligence provider, indicates that global spending on military electro optical and infra-red systems will reach $8.38bn in 2014.
Aug 15, 2014
A new report by visiongain calculates that the Alzheimer’s Disease Therapeutics and Diagnostics market will reach $7.0bn in 2014 with revenue showing strong overall growth to 2024, particularly beyond 2018.
Aug 14, 2014
LONDON, UK. 14th August 2014:Visiongain’s analysis indicates that the total value of the Automotive BYOD market revenues will reach $26.4 billion by the end of 2014. The Automotive BYOD market is set for exponential growth over the next few years.
Aug 08, 2014
Visiongain’s brand new report Top 16 Carbon Fibre Reinforced Plastic (CFRP) Composites Companies 2014: Leaders in Aerospace, Automotive, Energy, Construction & Sporting Goods analyses in detail the market share and competitive positioning of the...
Aug 06, 2014
A new report by visiongain forecasts the world cancer treating drugs market will achieve revenues of $122.3 billion in 2018.
Aug 05, 2014
LONDON, UK. 4th of August 2014: A new report by visiongain assesses that the healthcare packaging market is highly fragmented with the top 20 companies accounting for just 32% of the global healthcare packaging market in 2014.
Jul 24, 2014
LONDON, UK. 23rd July 2014: A new research report published today by leading business intelligence provider visiongain has revealed that the global aviation security market is valued at US$19,48bn in 2014.
Jul 21, 2014
The advent of connected devices and M2M is offering a tremendous opportunity for healthcare professionals. Near-ubiquitous mobile networks are allowing carers to diagnose, monitor, and communicate with patients with unprecedented speed and efficacy.
Jul 18, 2014
LONDON, UK, 18TH July 2014: A new report by visiongain calculates that the global prostate cancer therapeutics market will reach $7bn in 2014 with revenue showing strong growth to 2024.